Alzheimer's Research & Therapy

Resilience in Dementia Series

Wikimedia Commons

Brain resilience is the process of adapting well in the face of significant sources of stress, such as Alzheimer’s disease pathology, other neurodegenerative conditions or biological aging. This thematic series provides a comprehensive overview of what factors contribute to brain resilience and how this affects brain health and cognitive function.

Read the articles

Guest Editor: Rik Ossenkoppele

Publication: Ongoing but closed for submissions

Content type: Research
| 20 February 2019

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Authors: Philip S. J. Weston, Teresa Poole, Antoinette O’Connor, Amanda Heslegrave, Natalie S. Ryan, Yuying Liang, Ronald Druyeh, Simon Mead, Kaj Blennow, Jonathan M. Schott, Chris Frost, Henrik Zetterberg and Nick C. Fox
Content type: Research
| 12 February 2019

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease

Authors: Lutz Frölich, Glen Wunderlich, Claus Thamer, Michael Roehrle, Miguel Garcia Jr and Bruno Dubois
Content type: Research
| 4 February 2019

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease

Authors: Bernard J. Hanseeuw, Francisco Lopera, Reisa A. Sperling, Daniel J. Norton, Edmarie Guzman-Velez, Ana Baena, Enmanuelle Pardilla-Delgado, Aaron P. Schultz, Jennifer Gatchel, David Jin, Kewei Chen, Eric M. Reiman, Keith A. Johnson and Yakeel T. Quiroz
Content type: Research
| 2 February 2019

Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph

Authors: Lorenza Magno, Christian B. Lessard, Marta Martins, Verena Lang, Pedro Cruz, Yasmine Asi, Matilda Katan, Jamie Bilsland, Tammaryn Lashley, Paramita Chakrabarty, Todd E. Golde and Paul J. Whiting
Content type: Research
| 31 January 2019

¹⁸F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

Authors: Richard M. Tsai, Alexandre Bejanin, Orit Lesman-Segev, Renaud LaJoie, Adrienne Visani, Viktoriya Bourakova, James P. O’Neil, Mustafa Janabi, Suzanne Baker, Suzee E. Lee, David C. Perry, Lynn Bajorek, Anna Karydas, Salvatore Spina, Lea T. Grinberg, William W. Seeley…

Most recent articles RSS

View all articles

Content type: Research
| 15 March 2011

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice

Authors: Bin Li, Maria E Gonzalez-Toledo, Chun-Shu Piao, Allen Gu, Roger E Kelley and Li-Ru Zhao
Content type: Review
| 24 December 2014

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Authors: Robert Vassar
Content type: Research
| 3 July 2014

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Authors: Jeffrey L Cummings, Travis Morstorf and Kate Zhong
Content type: Research
| 1 August 2014

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Authors: Eva Kontsekova, Norbert Zilka, Branislav Kovacech, Petr Novak and Michal Novak
Content type: Review
| 11 June 2014

Cerebral microbleeds: overview and implications in cognitive impairment

Authors: Sergi Martinez-Ramirez, Steven M Greenberg and Anand Viswanathan

Most accessed articles RSS

View all articles

Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Latest Tweets

Alzheimer's blogs from BMC

Exergaming to improve complex motor-cognitive performances in patients suffering from dementia

07 February 2019
World Alzheimer’s Day: Every 3 seconds someone in the world develops dementia

21 September 2018
33rd International conference Alzheimer’s Disease International 2018

04 July 2018

Alzheimer's Research & Therapy

Resilience in Dementia Series

Articles

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease

Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph

¹⁸F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Cerebral microbleeds: overview and implications in cognitive impairment

Aims and scope

Latest Tweets

Alzheimer's blogs from BMC

Exergaming to improve complex motor-cognitive performances in patients suffering from dementia

World Alzheimer’s Day: Every 3 seconds someone in the world develops dementia

33rd International conference Alzheimer’s Disease International 2018

Affiliated with

2018 Journal Metrics

Alzheimer's Research & Therapy

Contact us